Journal article
A physiological role for androgen actions in the absence of androgen receptor DNA binding activity
TPS Pang, MV Clarke, A Ghasem-Zadeh, NKL Lee, RA Davey, HE MacLean
Molecular and Cellular Endocrinology | ELSEVIER IRELAND LTD | Published : 2012
Abstract
We tested the hypothesis that androgens have physiological actions via non-DNA binding-dependent androgen receptor (AR) signaling pathways in males, using our genetically modified mice that express a mutant AR with deletion of the 2nd zinc finger of the DNA binding domain (AR ΔZF2) that cannot bind DNA. In cultured genital skin fibroblasts, the mutant AR ΔZF2 has normal ligand binding ability, phosphorylates ERK-1/2 in response to 1min DHT treatment (blocked by the AR antagonist bicalutamide), but has reduced androgen-dependent nuclear localization compared to wildtype (WT). AR ΔZF2 males have normal baseline ERK-1/2 phosphorylation, with a 1.5-fold increase in Akt phosphorylation in AR ΔZF2..
View full abstractRelated Projects (3)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
We thank Rebecca Sawyer of the Hanson Institute for her excellent technical assistance. This work was supported by NHMRC (Australia) Project Grant Nos. 350334, 350346 and 509328 and Career Development Award No. 359226 (HEM); and an Endocrine Society of Australia Research Higher Degree Scholarship (TPSP). Funding sources were not involved in any aspects of the research study.